EXCHANGE TRADED CONCEPTS, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$1,220,950
+5.8%
42,189
+0.8%
0.03%0.0%
Q3 2023$1,153,915
+148.2%
41,854
+170.7%
0.03%
+200.0%
Q2 2023$464,848
-19.7%
15,464
-3.2%
0.01%
-31.2%
Q1 2023$578,738
-18.6%
15,974
-19.9%
0.02%
-20.0%
Q4 2022$711,188
+8.2%
19,938
+2.8%
0.02%
-9.1%
Q3 2022$657,000
+16.7%
19,398
-0.4%
0.02%
+37.5%
Q2 2022$563,000
-8.5%
19,472
+2.3%
0.02%
+33.3%
Q1 2022$615,000
-54.8%
19,028
-59.2%
0.01%
-53.8%
Q4 2021$1,360,000
+11.3%
46,635
+1.8%
0.03%
-16.1%
Q3 2021$1,222,000
+9.9%
45,822
+26.9%
0.03%
-11.4%
Q2 2021$1,112,000
+30.1%
36,105
+10.5%
0.04%
+9.4%
Q1 2021$855,000
+20.1%
32,672
+15.4%
0.03%
-3.0%
Q4 2020$712,000
+33.8%
28,310
+10.8%
0.03%
+10.0%
Q3 2020$532,000
+6.0%
25,550
+20.9%
0.03%
-63.9%
Q2 2020$502,00021,1360.08%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders